A new generation of FDA-approved diabetes drugs that can also help patients lose weight is prompting demand so strong that it's led to shortages.
Why it matters: At least 1 in 3 American adults meets the definition of obese, which can bring an increased risk of heart disease, diabetes, and certain cancers, per the CDC. The condition is estimated to cost the U.S. health care system nearly $173 billion a year.
